|
Volumn 44, Issue 7, 1999, Pages 639-645
|
Usefulness of platelet glycoprotein IIb/IIIa inhibitors in coronary stenting for reconstruction of complex lesions: procedural and 30 day outcome.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PROSPECTIVE STUDY;
RADIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
STENT;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
CORONARY DISEASE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROSPECTIVE STUDIES;
STENTS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0033160585
PISSN: 03931978
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|